CRESCENT BIOPHARMA, INC. (CBIO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CBIO currently has 13.9M outstanding shares. with significant dilution risk as 8.63M authorized shares could dilute existing holders by 62.1%. The company has minimally diluted shareholders by 0.07% over the past 2 years. Recent corporate actions include 1 stock split (positive for accessibility) and 1 reverse split (concerning signal).
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jan 07, 2026 |
S-1 filing: This prospectus relates to the proposed resale or other disposition by the selling securityholders of up to 19,710,257 ordinary shares. |
14M | 8.6M |
| Nov 06, 2025 |
10-Q filing | 13.9M shares outstanding |
14M | 0 |
| Jun 13, 2025 |
Stock Split
8-K filing: Stock split 1-for-100 | Outstanding: 64,522,257 → 13,900,000 |
14M | 0 |
| May 14, 2025 |
10-Q filing | 64.5M shares outstanding |
65M | 220M |
| Feb 13, 2025 |
10-K filing | 64.5M shares outstanding |
64M | 220M |
| Nov 13, 2024 |
10-Q filing | 64.5M shares outstanding |
64M | 220M |
| Aug 08, 2024 |
10-Q filing | 64.5M shares outstanding |
64M | 220M |
| May 09, 2024 |
10-Q filing | 64.5M shares outstanding |
64M | 220M |
| Mar 27, 2024 |
10-K filing | 63.3M shares outstanding |
63M | 220M |
| Nov 03, 2023 |
10-Q filing | 64.3M shares outstanding |
64M | 220M |
| Aug 02, 2023 |
10-Q filing | 64.3M shares outstanding |
64M | 220M |
| May 03, 2023 |
10-Q filing | 60.4M shares outstanding |
60M | 220M |
| Mar 29, 2023 |
10-K filing | 52.5M shares outstanding |
53M | 230M |
| Nov 09, 2022 |
10-Q filing | 52.4M shares outstanding |
52M | 230M |
| Aug 03, 2022 |
10-Q filing | 52.4M shares outstanding |
52M | 230M |
| Apr 28, 2022 |
10-Q filing | 52.3M shares outstanding |
52M | 230M |
| Mar 04, 2022 |
S-3 filing: The filing is an S-3 registration statement for a shelf offering of common stock, preferred stock, debt securities, and/or warrants, up to a total of $250,000,000. |
51M | 230M |
| Mar 03, 2022 |
10-K filing | 51.5M shares outstanding |
51M | 0 |
| Nov 02, 2021 |
10-Q filing | 51.7M shares outstanding |
52M | 0 |
| Aug 05, 2021 |
10-Q filing | 51.5M shares outstanding |
52M | 0 |
| May 03, 2021 |
10-Q filing | 51.5M shares outstanding |
52M | 0 |
| Mar 02, 2021 |
10-K filing | 49.0M shares outstanding |
49M | 0 |
| Nov 06, 2020 |
10-Q filing | 47.8M shares outstanding |
48M | 0 |
| Jul 31, 2020 |
10-Q filing | 46.7M shares outstanding |
47M | 0 |
| May 01, 2020 |
10-Q filing | 43.6M shares outstanding |
44M | 0 |
| Feb 28, 2020 |
10-K filing | 43.6M shares outstanding |
44M | 0 |